Enjin Co., Ltd. Logo

Enjin Co., Ltd.

PR firm for SMEs and medical institutions, offering consulting and a media matching platform.

7370 | T

Overview

Corporate Details

ISIN(s):
JP3168750002
LEI:
Country:
Japan
Address:
中央区銀座5−13−16
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Enjin Co., Ltd. is a public relations firm specializing in branding and strategic communications. The company provides comprehensive PR consulting services, including research, analysis, and long-term strategy development, primarily for small and medium-sized enterprises, corporations, and medical institutions. A key offering is "Medichoku," a proprietary media matching platform that connects clients directly with media outlets to secure exposure and enhance brand recognition. Additionally, Enjin operates a corporate venture capital arm to invest in and support startups, aiming to foster innovation and new market creation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-21 08:16
Registration Form
確認書
Japanese 8.7 KB
2025-08-21 08:15
Registration Form
有価証券報告書-第19期(2024/06/01-2025/05/31)
Japanese 1.0 MB
2025-06-17 07:27
Governance Information
訂正内部統制報告書-第16期(2021/06/01-2022/05/31)
Japanese 26.0 KB
2025-06-17 07:24
Governance Information
訂正内部統制報告書-第17期(2022/06/01-2023/05/31)
Japanese 26.6 KB
2025-06-17 07:19
Governance Information
訂正内部統制報告書-第18期(2023/06/01-2024/05/31)
Japanese 26.7 KB
2025-01-14 09:00
Report Publication Announcement
確認書
Japanese 8.8 KB
2025-01-14 08:54
Interim Report
半期報告書-第19期(2024/06/01-2025/05/31)
Japanese 219.6 KB
2024-08-26 08:02
Post-Annual General Meeting Information
臨時報告書
Japanese 28.9 KB
2024-08-26 07:51
Governance Information
内部統制報告書-第18期(2023/06/01-2024/05/31)
Japanese 23.3 KB
2024-08-26 07:44
Registration Form
確認書
Japanese 8.7 KB
2024-08-26 07:35
Registration Form
有価証券報告書-第18期(2023/06/01-2024/05/31)
Japanese 1008.8 KB
2024-04-12 08:17
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-04-12 08:13
Quarterly Report
四半期報告書-第18期第3四半期(2023/12/01-2024/02/29)
Japanese 167.8 KB
2024-01-12 07:42
Quarterly Report
確認書
Japanese 8.8 KB
2024-01-12 07:33
Quarterly Report
四半期報告書-第18期第2四半期(2023/09/01-2023/11/30)
Japanese 205.2 KB

Automate Your Workflow. Get a real-time feed of all Enjin Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enjin Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enjin Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France
POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan
2449
Predictive Oncology Inc. Logo
AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.
United States of America
POAI
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH
PROTHENA CORP PUBLIC LTD CO Logo
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
United States of America
PRTA
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America
950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America
PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel
PPBT
Qualigen Therapeutics, Inc. Logo
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
United States of America
QLGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.